Search Results
You are looking at 1 - 2 of 2 items for
- Author: J P H Wilding x
- Refine by access: All content x
Search for other papers by J P H Wilding in
Google Scholar
PubMed
Search for other papers by M O Ajala in
Google Scholar
PubMed
Search for other papers by P D Lambert in
Google Scholar
PubMed
Search for other papers by S R Bloom in
Google Scholar
PubMed
Neuropeptide Y (NPY) is the most powerful appetite stimulant known, and rates of synthesis and release in the hypothalamus correlate closely with nutritional status. Pregnancy and lactation provide an excellent model of physiological hyperphagia. In this study the authors measured food intake, plasma glucose, insulin and luteinizing hormone (LH) and hypothalamic NPY mRNA in rats during pregnancy and in early and late lactation. The effect of food restriction (to 80% of control) during lactation was also studied. Pregnancy resulted in a modest increase in daily food intake over non-lactating controls (controls: 15·6±0·6 g, pregnant: 19·8±1·1 g, P<0·01) During lactation food intake increased dramatically to 355% of non-lactating levels by the 12th day. Insulin and glucose levels were unchanged in lactation, except in the food-restricted animals, when insulin levels were reduced to 49·5±18·4 pmol/l compared with 215±55 pmol/l (P<0·01) in lactating, non-restricted animals, and glucose was reduced to 3·7±0·2 mmol/l compared with 5·1 ± 0·2 mmol/l in non-restricted lactating animals. Hypothalamic NPY mRNA was unchanged in pregnancy, moderately increased after 5 days lactation (130±6·2% of control, P<0·01) and increased further at 14 days lactation (179 ± 14%, P<0·001). The greatest changes occurred in the animals who were food-deprived during lactation, when hypothalamic NPY mRNA levels reached 324 ± 44% (P<0·001) of non-lactating levels. Increases in hypothalamic NPY synthesis may be partly responsible for the increase in food intake seen in lactation, but unlike in food deprivation, the increase is not related to circulating insulin, suggesting involvement of other regulatory factors.
Journal of Endocrinology (1997) 152, 365–369
Search for other papers by J. P. H. Wilding in
Google Scholar
PubMed
Search for other papers by S. G. Gilbey in
Google Scholar
PubMed
Search for other papers by M. Mannan in
Google Scholar
PubMed
Search for other papers by N. Aslam in
Google Scholar
PubMed
Search for other papers by M. A. Ghatei in
Google Scholar
PubMed
Search for other papers by S. R. Bloom in
Google Scholar
PubMed
ABSTRACT
Neuropeptide Y (NPY) is the most powerful appetite stimulant known, and chronic administration leads to obesity. The hypothalamic content of NPY varies with nutritional status, suggesting that it is of physiological importance. We measured NPY in specific hypothalamic nuclei and NPY mRNA in the hypothalamus by Northern blotting in rats made obese by feeding a highly palatable diet compared with controls fed standard chow. In animals fed the palatable diet, NPY concentrations were increased in the paraventricular nucleus (mean ± s.e.m.; 19·5 ± 2·3 vs 11·1 ± 1·1 fmol/μg protein, P < 0·02), the arcuate nucleus (20·4 ± 3·3 vs 9·3 ± 0·6 fmol/μg protein, P < 0·01), the medial preoptic area (9·1 ± 0·9 vs 5·9 ± 0·7 fmol/μg protein, P < 0·02) and the anterior hypothalamus (2·7 ± 0·2 vs 2·0 ± 0·1 fmol/μg, P < 0·02). Hypothalamic NPY mRNA measured by Northern blot analysis was, however, unchanged. These results suggest that the increase in NPY was due to decreased release rather than increased NPYergic activity. The findings are in accord with the neuroendocrine disturbance and increased thermogenesis observed in this model of obesity.
Journal of Endocrinology (1992) 132, 299–304